TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
Translational Development Acquisition Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.81−0.02 (-0.16%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Translational Development Acquisition statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Blank Checks companies for comparison
Valuation
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Market Cap | $208.73M | $304.72M |
| Enterprise Value | $208.64M | $295.22M |
Income (trailing twelve months)
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Operating Income | -$1.32M | -$564.40K |
| Net Income | $5.54M | $5.22M |
| EBITDA | -$1.32M | $5.99M |
Returns
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Return on Assets (ROA) | 3.30% | 1.79% |
| Return on Capital Employed (ROCE) | -0.85% | -0.75% |
Growth
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Net Income Growth (YoY) | 82.3% | 7.47% |
Balance sheet
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $85.88K | $1.14M |
| Net Cash (Debt) | $85.88K | $859.51K |
| Net Cash Per Share | $0.00 | $0.04 |
| Equity (Book Value) | -$7.68M | -$37.14K |
| Book Value Per Share | -$0.40 | -$0.00 |
| Tangible Book Value | -$7.68M | -$78.08K |
| Working Capital | -$1.65M | $316.11K |
Financial position
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Current Ratio | 0.06 | 2.04 |
| Quick Ratio | 0.05 | 1.57 |
Cash flow (trailing twelve months)
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Operating Cash Flow | -$849.38K | $15.25M |
Dividends and yields
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Earnings Yield | 2.65% | 2.10% |
Shares
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Shares Outstanding | 19,308,800 | 30,666,700 |
| Float | 19,308,800 | 24,340,100 |
| Shares Held by Insiders | 0.00% | 17.6% |
Scores
| Measure | Translational Development Acquisition | Industry median |
|---|---|---|
| Altman Z-Score | 15.97 | 6.12 |
Calculated by StockData from Translational Development Acquisition's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.